The Global Idiopathic Hypersomnia Treatment Market is Expected to Grow from USD 1.19 Billion in 2024 to USD 3.19 Billion by 2035, at a CAGR of 9.38% during the forecast period 2025 to 2035.Diagnosis of Idiopathic Hypersomnia involves ruling out other sleep disorders through clinical evaluation, sleep history, and tests like polysomnography (overnight sleep study) and the Multiple Sleep Latency Test (MSLT).

The Global Idiopathic Hypersomnia Treatment Market is Expected to Grow from USD 1.19 Billion in 2024 to USD 3.19 Billion by 2035, at a CAGR of 9.38% during the forecast period 2025 to 2035.Idiopathic Hypersomnia is a chronic sleep disorder marked by excessive daytime sleepiness despite adequate or prolonged nighttime sleep. Unlike narcolepsy, it lacks sudden sleep attacks or cataplexy.